eClinicalWorks vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 61)
eClinicalWorks logo

eClinicalWorks

ChallengerHealthcare

EHR Systems

Major ambulatory EHR serving 150K providers bootstrapped to scale; Sunoh.ai ambient clinical documentation and revenue cycle management competing with Epic and athenahealth for practices.

AI VisibilityBeta
Overall Score
B61
Category Rank
#121 of 596
AI Consensus
75%
Trend
up
Per Platform
ChatGPT
56
Perplexity
60
Gemini
61

About

eClinicalWorks is one of the largest electronic health record (EHR) and practice management software providers in the United States, serving approximately 150,000 providers across 850,000 care sites with ambulatory EHR, revenue cycle management, patient engagement, and population health tools. Founded in 1999 by Girish Navani and headquartered in Westborough, Massachusetts, eClinicalWorks is privately held and is notable for being a bootstrapped company that has grown to significant scale without venture capital funding, generating substantial annual revenue from its large installed physician base.\n\neClinicalWorks' platform covers the ambulatory (outpatient) clinical workflow: clinical documentation with specialty-specific templates, order entry for labs and imaging, e-prescribing, chronic disease management registries, telehealth (healow TeleVisits), and patient portal. The revenue cycle management capabilities handle insurance claims submission, denial management, and patient billing. Population health tools enable practices and health systems to identify at-risk patient populations and coordinate care across attributed patients.\n\nIn 2025, eClinicalWorks competes with Epic (the dominant health system EHR), athenahealth (cloud-native ambulatory EHR), Oracle Health (Cerner), and Modernizing Medicine for physician practice EHR market share. The company has faced regulatory challenges — in 2017, eClinicalWorks paid $155 million to settle Department of Justice charges related to EHR certification fraud. Despite this, the company retained most of its customer base due to high switching costs inherent in EHR changes. The 2025 strategy focuses on its AI assistant Sunoh.ai (ambient clinical documentation that automatically generates SOAP notes from recorded patient visits), expanding telehealth capabilities, and growing the healow patient engagement platform.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

61
Overall Score
88
#121
Category Rank
#3
75
AI Consensus
78
up
Trend
stable
56
ChatGPT
83
60
Perplexity
87
61
Gemini
85
66
Claude
90
56
Grok
92

Key Details

Category
EHR Systems
AI Drug Discovery
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only eClinicalWorks
EHR Systems
Only Amgen
AI Drug Discovery

Integrations

Both integrate with
Only Amgen
Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.